Pages that link to "Q41112386"

The following pages link to Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation (Q41112386):

Displaying 29 items.

• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward (Q33624574) (← links)
• DNA methylation in the tumor microenvironment (Q33722994) (← links)
• Chemotherapy and tumor microenvironment of pancreatic cancer. (Q33876637) (← links)
• Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells (Q38661469) (← links)
• Epigenetic control of the tumor microenvironment (Q38971785) (← links)
• Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts. (Q39204274) (← links)
• The role of stromal cancer-associated fibroblasts in pancreatic cancer. (Q39205210) (← links)
• Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression. (Q42682574) (← links)
• Tumor-stroma IL-1β-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer (Q49832519) (← links)
• Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. (Q55104265) (← links)
• Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1. (Q55167166) (← links)
• Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts. (Q55260595) (← links)
• Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. (Q55396890) (← links)
• Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers (Q58746789) (← links)
• The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer (Q59138139) (← links)
• Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells. (Q63888766) (← links)
• Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis (Q64259452) (← links)
• Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth (Q88615528) (← links)
• Precision medicine in pancreatic cancer: treating every patient as an exception (Q90067362) (← links)
• Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune "Defects" in the Tumor Microenvironment (Q90132915) (← links)
• Diagnostic and prognostic value of the BEX family in lung adenocarcinoma (Q90706194) (← links)
• CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer (Q91310930) (← links)
• DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade (Q93047925) (← links)
• The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities (Q94599849) (← links)
• Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma (Q96131459) (← links)
• Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment (Q97653022) (← links)
• Fibroblast Reprogramming in Gastrointestinal Cancer (Q98226255) (← links)
• Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer (Q101120968) (← links)
• Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression (Q104111289) (← links)